Cargando…

A case of low-grade fibromyxoid sarcoma with unusual central necrosis in a 77-year-old man confirmed by FUS-CREB3L2 gene fusion

INTRODUCTION: Low-grade fibromyxoid sarcoma (LGFMS) is a rare soft tissue tumor typically affecting young to middle-aged adults. Despite its otherwise benign histologic appearance and indolent nature, it can display fully malignant behavior, and recurrence and metastasis can occur even decades after...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurisaki-Arakawa, Aiko, Akaike, Keisuke, Tomomasa, Ran, Arakawa, Atsushi, Suehara, Yoshiyuki, Takagi, Tatsuya, Kaneko, Kazuo, Yao, Takashi, Saito, Tsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276325/
https://www.ncbi.nlm.nih.gov/pubmed/25437654
http://dx.doi.org/10.1016/j.ijscr.2014.09.034
_version_ 1782350239952273408
author Kurisaki-Arakawa, Aiko
Akaike, Keisuke
Tomomasa, Ran
Arakawa, Atsushi
Suehara, Yoshiyuki
Takagi, Tatsuya
Kaneko, Kazuo
Yao, Takashi
Saito, Tsuyoshi
author_facet Kurisaki-Arakawa, Aiko
Akaike, Keisuke
Tomomasa, Ran
Arakawa, Atsushi
Suehara, Yoshiyuki
Takagi, Tatsuya
Kaneko, Kazuo
Yao, Takashi
Saito, Tsuyoshi
author_sort Kurisaki-Arakawa, Aiko
collection PubMed
description INTRODUCTION: Low-grade fibromyxoid sarcoma (LGFMS) is a rare soft tissue tumor typically affecting young to middle-aged adults. Despite its otherwise benign histologic appearance and indolent nature, it can display fully malignant behavior, and recurrence and metastasis can occur even decades after diagnosis. PRESENTATION OF CASE: Herein, we report a case of LGFMS in the buttock of a 77-year-old man. Magnetic resonance imaging uncovered a well-demarcated tumor measuring 27 × 20 mm with a slightly high intensity on T1-weighted images (WIs) and heterogeneously high intensity on T2-WIs. Histologically, the tumor was composed of bland spindle-shaped cells in a whorled growth pattern with alternating fibrous and myxoid stroma. The tumor stroma was variably hyalinized with arcades of curvilinear capillaries and arterioles with associated perivascular fibrosis. Unusual histology, such as central necrosis and cystic formation, was also noted. Reverse transcription polymerase chain reaction from a formalin-fixed, paraffin-embedded biopsy specimen revealed a FUS-CREB3L2 gene fusion (exon6/int/exon5), leading to the diagnosis of LGFMS. DISCUSSION: To the best of our knowledge, this is the second oldest patient to be diagnosed with LGFMS. CONCLUSION: At the time of this report, the patient was alive with no evidence of the disease 4 months after diagnosis without any adjuvant therapy.
format Online
Article
Text
id pubmed-4276325
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-42763252014-12-28 A case of low-grade fibromyxoid sarcoma with unusual central necrosis in a 77-year-old man confirmed by FUS-CREB3L2 gene fusion Kurisaki-Arakawa, Aiko Akaike, Keisuke Tomomasa, Ran Arakawa, Atsushi Suehara, Yoshiyuki Takagi, Tatsuya Kaneko, Kazuo Yao, Takashi Saito, Tsuyoshi Int J Surg Case Rep Article INTRODUCTION: Low-grade fibromyxoid sarcoma (LGFMS) is a rare soft tissue tumor typically affecting young to middle-aged adults. Despite its otherwise benign histologic appearance and indolent nature, it can display fully malignant behavior, and recurrence and metastasis can occur even decades after diagnosis. PRESENTATION OF CASE: Herein, we report a case of LGFMS in the buttock of a 77-year-old man. Magnetic resonance imaging uncovered a well-demarcated tumor measuring 27 × 20 mm with a slightly high intensity on T1-weighted images (WIs) and heterogeneously high intensity on T2-WIs. Histologically, the tumor was composed of bland spindle-shaped cells in a whorled growth pattern with alternating fibrous and myxoid stroma. The tumor stroma was variably hyalinized with arcades of curvilinear capillaries and arterioles with associated perivascular fibrosis. Unusual histology, such as central necrosis and cystic formation, was also noted. Reverse transcription polymerase chain reaction from a formalin-fixed, paraffin-embedded biopsy specimen revealed a FUS-CREB3L2 gene fusion (exon6/int/exon5), leading to the diagnosis of LGFMS. DISCUSSION: To the best of our knowledge, this is the second oldest patient to be diagnosed with LGFMS. CONCLUSION: At the time of this report, the patient was alive with no evidence of the disease 4 months after diagnosis without any adjuvant therapy. Elsevier 2014-11-13 /pmc/articles/PMC4276325/ /pubmed/25437654 http://dx.doi.org/10.1016/j.ijscr.2014.09.034 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Article
Kurisaki-Arakawa, Aiko
Akaike, Keisuke
Tomomasa, Ran
Arakawa, Atsushi
Suehara, Yoshiyuki
Takagi, Tatsuya
Kaneko, Kazuo
Yao, Takashi
Saito, Tsuyoshi
A case of low-grade fibromyxoid sarcoma with unusual central necrosis in a 77-year-old man confirmed by FUS-CREB3L2 gene fusion
title A case of low-grade fibromyxoid sarcoma with unusual central necrosis in a 77-year-old man confirmed by FUS-CREB3L2 gene fusion
title_full A case of low-grade fibromyxoid sarcoma with unusual central necrosis in a 77-year-old man confirmed by FUS-CREB3L2 gene fusion
title_fullStr A case of low-grade fibromyxoid sarcoma with unusual central necrosis in a 77-year-old man confirmed by FUS-CREB3L2 gene fusion
title_full_unstemmed A case of low-grade fibromyxoid sarcoma with unusual central necrosis in a 77-year-old man confirmed by FUS-CREB3L2 gene fusion
title_short A case of low-grade fibromyxoid sarcoma with unusual central necrosis in a 77-year-old man confirmed by FUS-CREB3L2 gene fusion
title_sort case of low-grade fibromyxoid sarcoma with unusual central necrosis in a 77-year-old man confirmed by fus-creb3l2 gene fusion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276325/
https://www.ncbi.nlm.nih.gov/pubmed/25437654
http://dx.doi.org/10.1016/j.ijscr.2014.09.034
work_keys_str_mv AT kurisakiarakawaaiko acaseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT akaikekeisuke acaseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT tomomasaran acaseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT arakawaatsushi acaseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT sueharayoshiyuki acaseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT takagitatsuya acaseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT kanekokazuo acaseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT yaotakashi acaseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT saitotsuyoshi acaseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT kurisakiarakawaaiko caseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT akaikekeisuke caseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT tomomasaran caseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT arakawaatsushi caseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT sueharayoshiyuki caseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT takagitatsuya caseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT kanekokazuo caseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT yaotakashi caseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion
AT saitotsuyoshi caseoflowgradefibromyxoidsarcomawithunusualcentralnecrosisina77yearoldmanconfirmedbyfuscreb3l2genefusion